Uncategorized

Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

by Business Wire • 2020/08/04 • 0 Comments

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 11:00 a.m. EDT. In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporat

Full Story →

← Gyroscope Announces Appointment of Leaders in Retinal Disease, Gene Therapy and the Complement System to Its Clinical and Scientific Advisory Boards

Global Glaucoma Surgery Devices Market 2020-2025: Focus on Glaucoma Drainage Devices, Laser Systems, Punches, Probes, and Other Products – ResearchAndMarkets.com →

Post navigation